Jennifer Burstein
Director/Board Member chez STOKE THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Ms. Jennifer C.
Burstein is a Senior Vice President-Finance Operations at Treeline Biosciences, Inc. and an Independent Director at Stoke Therapeutics, Inc. She is on the Board of Directors at Stoke Therapeutics, Inc. Ms. Burstein was previously employed as a Senior Vice President-Finance by Loxo Oncology, Inc., a Vice President-Finance by Acorda Therapeutics, Inc., and a Senior Director-Accounting by Oldtech, Inc. She received her undergraduate degree from State University of New York at Buffalo and an MBA from State University of New York at Buffalo.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
STOKE THERAPEUTICS, INC.
-.--% | 01/09/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Jennifer Burstein
| Sociétés | Poste | Début |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Director/Board Member | 14/06/2019 |
Treeline Biosciences, Inc.
 Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Corporate Officer/Principal | 01/03/2021 |
Anciens postes connus de Jennifer Burstein
| Sociétés | Poste | Fin |
|---|---|---|
| LOXO ONCOLOGY INC | Director of Finance/CFO | 01/01/2019 |
| ACORDA THERAPEUTICS, INC. | Corporate Officer/Principal | 30/04/2015 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Comptroller/Controller/Auditor | 01/01/2006 |
Formation de Jennifer Burstein
| State University of New York at Buffalo | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| STOKE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT. | Health Technology |
Treeline Biosciences, Inc.
Treeline Biosciences, Inc. BiotechnologyHealth Technology Treeline Biosciences, Inc. develops transformative precision medicines for patients with cancer. The company is based in Stamford, CT. The company was founded by Joshua H. Bilenker. Joshua H. Bilenker has been the CEO since incorporation. | Health Technology |
